Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 412994Generated: October 29, 2026

HCID 105162, compound → HCID 10199679, compound

https://huagongshe.com/reaction/412994

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHCID 105162HCID 105162—
Reactant14333-33-6HCID 114789—
ReactantAmmonia-13NHCID 119432—
ReactantHCID 6918691HCID 6918691—
ReactantHCID 9902622HCID 9902622—
ReactantHCID 9923494HCID 9923494—
Reactant2-[1-methyl-5-(phenylsulfonyl)-1H-indol-3-yl]ethanamineHCID 9966632—
ReactantWater O 15HCID 10129877—
ReactantHCID 10133372HCID 10133372—
ReactantHCID 10177681HCID 10177681—
ProductHCID 10199679HCID 10199679—

Reaction Steps

The compounds of formula I also can include isotopic labels. For example the compounds 2-[1-methyl-5-(phenylsulfonyl)-1H-indol-3-yl]ethanamine; 2-[1,2-dimethyl-5-(phenylsulfonyl)-1H-indol-3-yl]-N-methylethanamine; 2-[1,2-dimethyl-5-(phenylsulfonyl)-1H-indol-3-yl]ethanamine; 2-{5-[(3,5-difluorophenyl)sulfonyl]-1,2-dimethyl-1H-indol-3-yl}ethanamine; 2-{5-[(3,5-difluorophenyl)sulfonyl]-1,2-dimethyl-1H-indol-3-yl}-N-methylethanamine; 2-[2-methyl-5-(1-naphthylsulfonyl)-1H-indol-3-yl]ethanamine; and pharmaceutically acceptable salts thereof may contain an isotopic label such as at least one atom selected from Carbon-11, Nitrogen-13, Oxygen-15, and Fluorine-18. Isotopically labeled compounds may be used in positron emission tomography.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06565829B2
Source datasetuspto-grants-2003_05
ORD IDord-d8b2dfdd32ed4db59c92656af18bcf5a
Source noteuspto-grants-2003_05